Cibolo Health Designates MyoVista Insights as Endorsed ECG Management Platform for 123 Hospitals

Southlake, TX — HeartSciences Inc. (Nasdaq: HSCS / HSCSW), a healthcare information technology (HIT) company focused on advancing electrocardiography (ECG/EKG) through the integration of artificial intelligence (AI), today announced that Cibolo Rural Health Networks ("Cibolo Health") has selected MyoVista Insights as its endorsed ECG management platform for independent hospitals within its high-value networks.

This collaboration will provide Cibolo Health's network of 123 independent hospitals across six states with access to a modern, cloud-native ECG management platform designed to improve workflow efficiency, data accessibility, and clinical decision-making.

Through this partnership, HeartSciences will support Cibolo Health in enabling its member hospitals to modernize legacy ECG workflows, allowing physicians to interpret ECGs more quickly and efficiently without disrupting existing clinical processes. MyoVista Insights delivers secure, cloud-based ECG data management across a wide range of devices and file formats while providing a scalable foundation for the integration of regulatory-compliant AI-ECG algorithms directly into routine clinical practice.

"We are delighted to partner with Cibolo Health, which is focused on ensuring its member hospitals and clinics have access to best-in-class solutions that support high-quality, cost-effective care," said Andrew Simpson, CEO of HeartSciences. "This collaboration represents an important step in expanding access to our MyoVista Insights platform across a broad network of independent hospitals."